Ruilin Biomedical Nanjing Co.
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $36M
Investors
- 5
About Ruilin Biomedical Nanjing Co.
, Ltd. operates as a regenerative medicine technology developer that provides tissue and organ repair and regeneration products. Xing Zhao is the founder of the company, who served as lecturer of Orthopaedic at Harvard University, and served as researcher in Vericel Corporation that is a regenerative medicine public enterprise. The company established plant with 2,000 square meters in Nanjing. The company provides tissue and organ repair and regeneration products. It adopts organic combination technology of multi-source cells and 3D printed bio-scaffold materials. Its products focus on orthopaedic sports medicine and plastic surgery fields, including articular hyaline cartilage, osteochondral, meniscal repair and external ear reconstruction.
Who invested in Ruilin Biomedical Nanjing Co.
5 investors across 2 rounds
See all investors in Ruilin Biomedical Nanjing Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ruilin Biomedical Nanjing Co.
Who invested in Ruilin Biomedical Nanjing Co.?
Ruilin Biomedical Nanjing Co. has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruilin Biomedical Nanjing Co. raised?
Ruilin Biomedical Nanjing Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ruilin Biomedical Nanjing Co. last raise money?
Ruilin Biomedical Nanjing Co.'s most recent round on record is a Series A, in Jan 2023.
What does Ruilin Biomedical Nanjing Co. do?
Ruilin Biomedical Nanjing Co. is a healthcare specialists company.
Where is Ruilin Biomedical Nanjing Co. headquartered?
Ruilin Biomedical Nanjing Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Ruilin Biomedical Nanjing Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Ruilin Biomedical Nanjing Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Ruilin Biomedical Nanjing Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.